Guardant Health
GH
#1530
Rank
S$17.55 B
Marketcap
S$135.18
Share price
2.11%
Change (1 day)
177.13%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total assets

Total assets on the balance sheet as of September 2025 : S$1.65 Billion

According to Guardant Health 's latest financial reports the company's total assets are S$1.65 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Guardant Health - Total assets on balance sheet (from 2017 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$2.01 B-14.41%
2023-12-31S$2.35 B9.31%
2022-12-31S$2.15 B-27.58%
2021-12-31S$2.98 B-0.84%
2020-12-31S$3.00 B131.6%
2019-12-31S$1.29 B61.71%
2018-12-31S$0.80 B74.95%
2017-12-31S$0.45 B171.88%
2016-12-31S$0.16 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Natera
NTRA
S$2.36 B 42.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
S$4.38 B 164.58%๐Ÿ‡บ๐Ÿ‡ธ USA